Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,598.00
Bid: 1,590.00
Ask: 1,718.00
Change: 0.00 (0.00%)
Spread: 128.00 (8.05%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,598.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Credit Suisse Upgrades TUI Travel To Outperform

Thu, 11th Sep 2014 08:35

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
TRADERS: CREDIT SUISSE RAISES TUI TRAVEL TO 'OUTPERFORM' ('NEUTRAL')
----------
UBS RAISES IMPERIAL TOBACCO PRICE TARGET TO 2,900 (2,750) PENCE - 'BUY'
----------
SOCGEN CUTS KINGFISHER PRICE TARGET TO 315 (320) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS KINGFISHER PRICE TARGET TO 415 (430) PENCE - 'BUY'
----------
NOMURA RAISES KINGFISHER PRICE TARGET TO 335 (330) PENCE - 'NEUTRAL'
----------
NUMIS RAISES ADMIRAL GROUP TO 'BUY' ('ADD') - TARGET 1630 (1720) PENCE
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 4240 (3775) PENCE - 'HOLD'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1575 (1520) PENCE - 'HOLD'
----------
GOLDMAN CUTS ASSOCIATED BRITISH FOODS PRICE TARGET TO 2,550 (2,600)P - 'SELL'
----------
CITIGROUP RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 465 (460) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES BARRATT DEVELOPMENTS TARGET TO 506 (475) PENCE - 'BUY'
----------
NOMURA RAISES WHITBREAD PRICE TARGET TO 4875 (4770) PENCE - 'BUY'
----------
CITIGROUP RAISES SMITHS GROUP PRICE TARGET TO 1,270 (1,224) PENCE - 'SELL'
----------
JEFFERIES RAISES PERSIMMON PRICE TARGET TO 1,567 (1,461) PENCE - 'HOLD'
----------
NUMIS INITIATES LONDON STOCK EXCHANGE WITH 'HOLD' - TARGET 2,074 PENCE
----------
FTSE 250
----------
TRADERS: MORGAN STANLEY RESUMES POLYMETAL WITH 'EQUAL-WEIGHT' - TARGET 535P
----------
GOLDMAN RAISES BIG YELLOW GROUP TARGET TO 665 (654)P - 'CONVICTION BUY LIST'
----------
TRADERS: PANMURE RESUMES INFORMA WITH 'BUY' - TARGET 620 PENCE
----------
GOLDMAN RAISES BIG YELLOW GROUP TARGET TO 665 (654)P - 'CONVICTION BUY LIST'
----------
HSBC CUTS WILLIAM HILL TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 365 (385) PENCE
----------
HSBC CUTS LADBROKES PRICE TARGET TO 120 (125) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES BETFAIR PRICE TARGET TO 1,280 (1,230) PENCE - 'OVERWEIGHT'
----------
EXANE BNP INITIATES SPIRAX-SARCO WITH 'UNDERPERFORM' - TARGET 2,600 PENCE
----------
CANACCORD CUTS ASHMORE GROUP TO 'SELL' ('HOLD') - TARGET 300 (360) PENCE
----------
NUMIS CUTS DIRECT LINE TO 'HOLD' ('ADD') - TARGET 305 (300) PENCE
----------
NUMIS CUTS ESURE GROUP PRICE TARGET TO 285 (320) PENCE - 'ADD'
----------
MORGAN STANLEY RAISES BWIN.PARTY TO 'EQUAL-WEIGHT' ('UNDERWEIGHT')
----------
MORGAN STANLEY CUTS BWIN.PARTY PRICE TARGET TO 100 (105) PENCE
----------
MAIN MARKET AND AIM
----------
LIBERUM INITIATES BURFORD CAPITAL WITH 'BUY' - PRICE TARGET 156P
----------
LIBERUM INITIATES JURIDICA INVESTMENTS WITH 'BUY' - TARGET 157P
----------
NUMIS RAISES M&C SAATCHI PRICE TARGET TO 380 (369)P - 'BUY'
----------
MACQUARIE RAISES PURECIRCLE PRICE TARGET TO 700 (650) PENCE - 'OUTPERFORM'
----------
MACQUARIE CUTS HANSARD GLOBAL PRICE TARGET TO 120 (130) PENCE - 'OUTPERFORM'
----------
CANACCORD RAISES ADVANCED MEDICAL SOLUTIONS PRICE TARGET TO 112 (101)P - 'HOLD'
----------
CANACCORD CUTS ALLIANCE PHARMA PRICE TARGET TO 35 (38) PENCE - 'HOLD'
----------
CANACCORD CUTS PETROPAVLOVSK PRICE TARGET TO 70 (85) PENCE - 'SPECULATIVE BUY'
----------
SHORE CAPITAL CUTS STHREE TO 'HOLD' ('BUY') - TARGET 344 PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.